Year Ended December 31,2021,2022,2023
Operating activities,76,033,59,972,73,795
Net income,,,,
Adjustments:,,,
Depreciation of property and equipment,10,273,13,475,11,946
Stock-based compensation expense,15,376,19,362,22,460
Deferred income taxes,1,808,-8,081,-7,763
(Gain) loss on debt and equity securities, net,-12,270,5,519,823
Other,1,955,3,483,4,330
Changes in assets and liabilities, net of effects of acquisitions:,,,
Accounts receivable, net,-9,095,-2,317,-7,833
Income taxes, net,-625,584,283
Other assets,-1,846,-5,046,-2,143
Accounts payable,523,2,143,707
Deferred revenue,-2,143,664,664
Accrued expenses and other liabilities,7,304,3,915,3,937
Accrued revenue share,1,682,-445,482
Net cash provided by operating activities,91,652,91,495,101,746
Investing activities,,,
Purchases of property and equipment,-24,640,-31,485,-32,251
Purchases of marketable securities,-135,196,-78,874,-77,858
Maturities and sales of marketable securities,128,294,97,822,86,672
Purchases of non-marketable securities,-2,838,-2,531,-3,027
Maturities and sales of non-marketable securities,934,150,947
Acquisitions, net of cash acquired, and purchases of intangible assets,-2,616,-6,969,-495
Other investing activities,541,1,589,-1,051
Net cash used in investing activities,-35,523,-20,298,-27,063
Financing activities,,,
Net payments related to stock-based award activities,-10,162,-9,300,-9,837
Repurchases of stock,-50,274,-59,296,-61,504
Proceeds from issuance of debt, net of costs,20,199,52,872,10,790
Repayments of debt,-21,435,-54,068,-11,550
Proceeds from sale of interest in consolidated entities, net,310,35,8
Net cash used in financing activities,-61,362,-69,757,-72,093
Effect of exchange rate changes on cash and cash equivalents,-287,-506,-421
Net increase (decrease) in cash and cash equivalents,-5,520,934,2,169
Cash and cash equivalents at beginning of period,26,465,20,945,21,879